Comparison of the Computed Structures for the Phosphate-Binding Loop of the p21 Protein Containing the Oncogenic Site Gly 12 with the X-ray Crystallographic Structures for this Region in the p21 Protein and EFtu. A Model for the Structure of the p21 Protein in its Oncogenic Form
- 1 April 1989
- journal article
- research article
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 6 (5) , 859-875
- https://doi.org/10.1080/07391102.1989.10506518
Abstract
The GTP-binding p21 protein encoded by the ras-oncogene can be activated to cause malignant transformation of cells by substitution of a single amino acid at critical positions along the polypeptide chain. Substitution of any non-cyclic L-amino acid for Gly 12 in the normal protein results in a transforming protein. This substitution occurs in a hydrophobic sequence (residues 6–15) which is known to be involved in binding the phosphate moities of GTP (and GDP). We find, using conformational energy calculations, that the 6–15 segment of the normal protein (with Gly 12) adopts structures that contain a bend at residues 11 and 12 with the Gly in the D* conformation, not allowed energetically for L-amino acids. Substitution of non-cyclic L-amino acids for Gly 12 results in shifting this bend to residues 12 and 13. We show that many computed structures for the Gly 12-containing phosphate binding loop, segment 9–15, are superimposable on the corresponding segment of the recently determined X-ray crystallographic structure for residues 1–171 of the p21 protein. All such structures contain bends at residues 11 and 12 and most of these contain Gly 12 in the C* or D* conformational state. Other computed conformations for the 9–15 segment were superimposable on the structure of the corresponding 18–23 segment of EFtu, the bacterial chain elongation factor having structural similarities to the p21 protein in the phosphate- binding regions. This segment contains a Val residue where a Gly occurs in the p21 protein. As previously predicted, all of these superimposable conformations contain a bend at positions 12 and 13, not 11 and 12. If these structures that are superimposable on EFtu are introduced into the p21 protein structure, bad contacts occur between the sidechain of the residue (here Val) at position 12 and another phosphate binding loop region around position 61. These bad contacts between the two segments can be removed by changing the conformation of the 61 region in the p21 protein to the corresponding position of the homologous region in EFtu. In this new conformation, a large site becomes available for the binding of phosphate residues. In addition, such phenomena as autophosphorylation of the p21 protein by GTP can be explained with this new model structure for the activated protein which cannot be explained by the structure for the non-activated protein.This publication has 39 references indexed in Scilit:
- Cloning of bovine GAP and its interaction with oncogenic ras p21Nature, 1988
- Three-Dimensional Structure of an Oncogene Protein: Catalytic Domain of Human c-H- ras P21Science, 1988
- ras GENESAnnual Review of Biochemistry, 1987
- G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALSAnnual Review of Biochemistry, 1987
- Protein Structure and CancerCancer Investigation, 1986
- Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity.Proceedings of the National Academy of Sciences, 1985
- Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.Proceedings of the National Academy of Sciences, 1984
- Comparative biochemical properties of normal and activated human ras p21 proteinNature, 1984
- A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogeneNature, 1982
- Mechanism of activation of a human oncogeneNature, 1982